1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Prostatic Neoplasms in 1 studies
1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nithipatikom, K | 1 |
| Endsley, MP | 1 |
| Isbell, MA | 1 |
| Falck, JR | 1 |
| Iwamoto, Y | 1 |
| Hillard, CJ | 1 |
| Campbell, WB | 1 |
1 other study available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Prostatic Neoplasms
| Article | Year |
|---|---|
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.
Topics: Androgens; Arachidonic Acids; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cyclohexanones | 2004 |